Stock GTG GENETIC TECHNOLOGIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Genetic Technologies Limited

Equities

GTG

AU000000GTG7

Healthcare Facilities & Services

Market Closed - Australian S.E.
Other stock markets
 01:47:11 2024-04-26 am EDT 		5-day change 1st Jan Change
0.12 AUD +4.35% Intraday chart for Genetic Technologies Limited -14.29% -11.11%
Apr. 19 Genetic Technologies Raising $2 Million via ADS Offering MT
Apr. 18 Top Midday Decliners MT

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 24.35 17.63 37.57 76.64 27.7 28.85
Enterprise Value (EV) 1 18.86 15.5 23.84 55.94 16.61 21.52
P/E ratio -4.46 x -2.46 x -3.41 x -10.3 x -3.88 x -2.16 x
Yield - - - - - -
Capitalization / Revenue 129 x 693 x 3,809 x 636 x 3.01 x 2.79 x
EV / Revenue 99.7 x 609 x 2,417 x 464 x 1.8 x 2.08 x
EV / EBITDA -3.03 x -2.64 x -3.62 x -6.7 x -2.31 x -2.14 x
EV / FCF -5.32 x -4.02 x -5.63 x -10.7 x -5.32 x -3.7 x
FCF Yield -18.8% -24.9% -17.8% -9.37% -18.8% -27%
Price to Book 5.17 x 9.95 x 2.89 x 3.56 x 1.69 x 2.58 x
Nbr of stocks (in thousands) 24,353 29,381 75,138 90,167 92,340 115,417
Reference price 2 1.000 0.6000 0.5000 0.8500 0.3000 0.2500
Announcement Date 8/29/18 9/30/19 8/31/20 8/30/21 8/30/22 8/30/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 0.1893 0.0254 0.009864 0.1206 9.218 10.35
EBITDA 1 -6.228 -5.868 -6.585 -8.346 -7.201 -10.04
EBIT 1 -6.532 -6.024 -6.628 -8.612 -7.544 -10.42
Operating Margin -3,451.4% -23,675.06% -67,190.82% -7,143.43% -81.84% -100.66%
Earnings before Tax (EBT) 1 -5.464 -6.426 -6.099 -7.078 -7.163 -11.91
Net income 1 -5.464 -6.426 -6.099 -7.078 -7.131 -11.75
Net margin -2,887.06% -25,253.91% -61,830.19% -5,870.91% -77.36% -113.56%
EPS 2 -0.2244 -0.2438 -0.1468 -0.0828 -0.0773 -0.1159
Free Cash Flow 1 -3.543 -3.854 -4.235 -5.244 -3.124 -5.812
FCF margin -1,872.32% -15,148.5% -42,935.9% -4,349.52% -33.88% -56.17%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 8/29/18 9/30/19 8/31/20 8/30/21 8/30/22 8/30/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 5.49 2.13 13.7 20.7 11.1 7.34
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -3.54 -3.85 -4.24 -5.24 -3.12 -5.81
ROE (net income / shareholders' equity) -71.5% -198% -82.5% -39.8% -37.6% -85.2%
ROA (Net income/ Total Assets) -44.7% -79.8% -43.8% -27.9% -21.5% -36.5%
Assets 1 12.23 8.048 13.91 25.38 33.1 32.18
Book Value Per Share 2 0.1900 0.0600 0.1700 0.2400 0.1800 0.1000
Cash Flow per Share 2 0.2300 0.0700 0.1900 0.2300 0.1300 0.0700
Capex 1 0 0.05 0.04 0.75 0.06 0.02
Capex / Sales 1.26% 197.72% 386.25% 621.05% 0.69% 0.17%
Announcement Date 8/29/18 9/30/19 8/31/20 8/30/21 8/30/22 8/30/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
GENETIC TECHNOLOGIES LIMITED Stock Genetic Technologies Limited
-11.11% 10.35M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
DAVITA INC. Stock DaVita Inc.
+27.44% 11.71B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. GTG Stock
  4. Financials Genetic Technologies Limited